This article was originally published in The Gray Sheet
Executive SummaryDiapulse asks CMS to reconsider its noncoverage of electromagnetic therapy for wounds. A decision is expected mid-January...
You may also be interested in...
CMR Surgical CEO Martin Frost is making way for a new boss to lead the surgical robotics company. Per Vegard Nerseth is set to join CMR Surgical in January 2020 as the company gears up for its most ambitious year yet.
While the BCMA-targeting CAR-T competition is grabbing attention, bluebird has good news in sickle cell therapy.
AstraZeneca’s Lynparza can now be used on the Scottish National Health Service for newly diagnosed advanced ovarian cancer.